| abstract |
FIELD: pharmaceutical industry.SUBSTANCE: group of inventions relates to a composition for treating excessive bleeding in a subject, and a method of treating excessive bleeding in a subject. Composition contains erythrocyte-derived microparticles (RMP) for treating excessive bleeding in a subject, where microparticles obtained from erythrocytes demonstrate acetylcholinesterase (AchE) activity, which is less than 350 pmol/min per 106 particles/mcl. Method of treating excessive bleeding in a subject.EFFECT: above-described composition retains high haemostatic efficacy, at the same time does not demonstrate noticeable toxicity.16 cl, 2 tbl, 4 dwg, 1 ex |